Skip to content

Gross margin at other companies

WAT
Waters CorporationWAT
59.3%-0.1pp
CryoPort, Inc. logo
CryoPort, Inc.CYRX
47.2%+1.6pp
Lifetime Brands logo
Lifetime BrandsLCUT
37.5%+0.2pp
Opko Health logo
Opko HealthOPK
36%+4.2pp
Healthpeak Properties logo
Healthpeak PropertiesDOC
60.1%+0.1pp
Ecolab logo
EcolabECL
44.3%+0.6pp

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-34.8%
Enterprise value$117.3M-28.0%
P/E10.6×-3.1×
P/S0.4×-0.3×

Profitability

See full
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Calculated from Kewaunee Scientific Corporation’s reported figures.

Based on trailing twelve months.

The official record: Kewaunee Scientific Corporation’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's gross margin?
Kewaunee Scientific Corporation (KEQU) reported gross margin of 28.5% in Q1 2026.
How has Kewaunee Scientific Corporation's gross margin changed year-over-year?
Kewaunee Scientific Corporation's gross margin decreased by 0.4% year-over-year, from 28.6% to 28.5%.
What is the long-term trend for Kewaunee Scientific Corporation's gross margin?
Over 5 years (2021 to 2026), Kewaunee Scientific Corporation's gross margin has grown at a 11.9% compound annual growth rate (CAGR), from 16.3% to 28.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.